Sales Performance - Fourth quarter sales were $744 million, a 4% increase from $719 million in the prior year[2] - Full year sales reached a record $2.7 billion, reflecting a 2% growth over last year's record sales of $2.628 billion[10] - The Advanced Technology Solutions segment saw a 5% increase in sales to $152 million, driven by a 4% organic sales increase[9] - The Medical and Fluid Solutions segment reported a 19% increase in sales to $200 million, primarily due to the Atrion acquisition[7] - The Industrial Precision Solutions segment experienced a 3% decrease in sales to $392 million, driven by a 5% organic sales decrease[6] - The Industrial Precision Solutions segment reported sales of $1,484,249 thousand for the twelve months ended October 31, 2024, a 6.7% increase from $1,391,046 thousand in 2023[32] - The Medical and Fluid Solutions segment saw a 5.3% increase in sales to $695,452 thousand for the twelve months ended October 31, 2024, compared to $660,316 thousand in the previous year[32] - Total sales for the three months ended October 31, 2024, were $744,482 thousand, representing a 3.5% increase compared to $719,313 thousand for the same period in 2023[32] - The industrial precision solutions segment reported sales of $392,150 thousand for the three months ended October 31, 2024, a decrease of 3.3% from $405,436 thousand in the same period last year[38] - Medical and fluid solutions segment sales increased to $200,223 thousand, up 18.7% from $168,632 thousand in the prior year[38] - Advanced technology solutions segment sales were $152,109 thousand, a 4.0% increase from $145,245 thousand in the same period last year[38] Earnings and Profitability - Adjusted earnings per diluted share for the fourth quarter were $2.78, up from $2.71 in the prior year[3] - Full year adjusted earnings per diluted share were $9.73, compared to $9.85 in the prior year[11] - Operating profit for the three months ended October 31, 2024, was $178,892 thousand, down 3.1% from $185,039 thousand in the prior year[38] - Adjusted net income for the three months ended October 31, 2024, was $160,239 thousand, compared to $156,025 thousand for the same period in 2023, reflecting a 1.4% increase[42] - Diluted earnings per share for the three months ended October 31, 2024, were $2.12, a decrease from $2.22 in the same period last year[42] Cash Flow and Financial Position - Cash flows from operating activities for the twelve months ended October 31, 2024, totaled $556,193 thousand, a decrease of 13.3% from $641,282 thousand in 2023[29] - The company’s cash and cash equivalents at the end of the period were $115,952 thousand, slightly up from $115,679 thousand at the beginning of the period[29] - Free cash flow for the year to date as of October 31, 2024, was $491,783 thousand, compared to $416,026 thousand for the same period in 2023, indicating a 18.1% increase[45] EBITDA and Backlog - EBITDA for the fourth quarter was $241 million, representing 32% of sales, a 4% increase from $227 million in the prior year[4] - EBITDA for the twelve months ended October 31, 2024, was $849,168 thousand, an increase from $818,974 thousand in the previous year, reflecting a growth of 3.7%[35] - EBITDA for the three months ended October 31, 2024, was $241,096 thousand, representing a 6.1% increase from $227,100 thousand in the prior year[38] - The company has approximately $580 million in backlog entering fiscal 2025[14] Assets and Liabilities - The company reported a total current assets increase to $1,275,032 thousand as of October 31, 2024, compared to $1,229,310 thousand in 2023, marking a growth of 3.7%[26] - Long-term debt increased to $2,101,197 thousand as of October 31, 2024, up from $1,621,394 thousand in the previous year, indicating a rise of 29.5%[26] - The company’s total shareholders' equity increased to $2,932,192 thousand as of October 31, 2024, compared to $2,598,060 thousand in 2023, representing a growth of 12.8%[26]

Nordson Corporation (NDSN) has been witnessing strength in the Industrial Precision Solutions segment, driven by the solid demand for its packaging and nonwoven product lines. Growing popularity for the fluid solutions product line in the industrial and electronics end markets is aiding the Medical and Fluid Solutions segment’s revenues. The company anticipates to generate sales in the range of $2.665-$2.705 billion in fiscal 2024, implying year-over-year growth of 2.1% at the midpoint.The company remains f ...

Nordson (NDSN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. Individual investors ofte ...

Nordson Corporation (NDSN) has been benefiting from solid momentum in the Industrial Precision Solutions segment, driven by the growing popularity of its packaging and nonwoven product lines. Solid demand for the fluid solutions product line in the industrial and electronics end markets is aiding the Medical and Fluid Solutions segment's revenues. Driven by strength across its businesses, the company expects sales to be in the range of $2.665-$2.705 billion in fiscal 2024, implying year-over-year growth of ...

It has been about a month since the last earnings report for Nordson (NDSN) . Shares have added about 1.6% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Nordson due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Nordson Beats on Q3 Earnings, Sales Rise Y/Y Nords ...

Nordson Corporation (NDSN) is well-poised for growth, courtesy of strength across its businesses and accretive acquisitions. Handsome rewards to shareholders add to the stock's appeal. Headquartered in Westlake, OH, Nordson is one of the leading manufacturers as well as distributors of products and systems designed to dispense, apply and control adhesives, coatings, polymers, sealants, biomaterials and other fluids. The company's product line includes single-use components, stand-alone units for low-volume ...

Financial Data and Key Metrics - Q3 2024 sales were $662 million, up 2% YoY, driven by a 4% increase from the ARAG acquisition, partially offset by a 1% organic sales decrease and unfavorable currency translation [7] - Adjusted EPS for the quarter was $2.41, $0.08 above the midpoint of guidance but a 6% decrease YoY [9] - Free cash flow was $143 million, representing a 122% conversion rate on net income [6] - EBITDA margin was 31.5%, slightly below the prior year by 50 basis points due to higher selling and administrative costs [8] Business Segment Performance Industrial Precision Solutions (IPS) - Sales increased 10% YoY to $371 million, driven by a 7% contribution from the ARAG acquisition and 4% organic growth [10] - EBITDA for the segment was $135 million, or 36% of sales, up 10% YoY [10] Medical and Fluid Solutions (MFS) - Sales decreased 2% YoY to $167 million due to lower demand in medical interventional solutions and fluid components [11] - EBITDA was $62 million, or 37% of sales, a 9% reduction YoY [11] Advanced Technology Solutions (ATS) - Sales decreased 11% YoY to $124 million, driven by a 10% organic volume decline and unfavorable currency translation [12] - EBITDA was $26 million, or 21% of sales, below the prior year [12] Market Data and Key Metrics - The IPS segment saw steady growth in industrial and consumer non-durable end markets, with nonwovens picking up in Q3 [15] - The ATS segment is expected to benefit from increasing demand for advanced chips, automotive electronics, and the CHIPS Act [17] - Medical device customers are being more cautious with inventory purchases, leading to lower demand in certain product lines [16] Company Strategy and Industry Competition - The company continues to focus on top customers and differentiated products, improving product mix and managing costs [6] - The acquisition of Atrion Medical expands the company's addressable market in medical fluid components by more than 50% [5] - The company is leveraging the NBS Next growth framework to drive operational efficiency and growth [5] Management Commentary on Operating Environment and Future Outlook - Management expects the ATS segment to return to growth in 2025, driven by sequential and YoY increases in order entry [17] - Full-year fiscal 2024 adjusted EPS is expected to be in the range of $9.45 to $9.65, unchanged at the midpoint despite the inclusion of Atrion [19] - The company remains confident in the long-term growth drivers of the medical and fluid solutions segment, including aging populations and increased healthcare spending [16] Other Important Information - The company announced its 61st year of increasing its annual dividend, reflecting a commitment to growing capital returns [14] - The Atrion acquisition was funded with a $500 million term loan, cash on hand, and borrowings on the revolver, increasing net debt to $2.2 billion and leverage ratio to 2.5x [13] Q&A Session Summary Question: Atrion's Margin Profile and Steps to Improve - Management believes Atrion's EBITDA margins can return to Nordson-like levels over time, addressing supply chain and operational issues [21] Question: Growth in Test and Inspection Products - Strong momentum in optical and acoustic product lines, driven by new products and the semiconductor manufacturing cycle [23] Question: Implied Guidance for Q4 and Organic Growth - The company expects steady performance in IPS, with modest order entry pickup in ATS and cautious inventory management in MFS [26] Question: Medical Interventional Solutions Normalization - Management sees conservative order patterns from medical device customers, with long-term growth drivers intact but near-term softness [31] Question: Atrion's Revenue and Margin Expectations - Atrion is expected to achieve mid-single-digit growth, with EBITDA margins returning to historical levels by 2026 [29] Question: M&A Strategy and Pipeline - The company remains committed to a balanced acquisition-led growth strategy, with a healthy pipeline and disciplined financial criteria [36] Question: Geographic Performance and Market Shifts - The US market remains strong, with Asia-Pacific recovering and Europe showing weaker organic growth [43] Question: Backlog and Systems Normalization - Backlog remains weighted to system businesses, with book-and-ship businesses returning to normal order entry patterns [45] Question: ARAG Margin Performance - ARAG is performing at Nordson-like EBITDA margins, with integration progressing well despite market weakness [47]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-7977 | --- | |--------------------------------------------------------------------------------------------------------------------- ...

Nordson Corporation's (NDSN) third-quarter fiscal 2024 (ended Jul 31, 2024) adjusted earnings of $2.41 per share surpassed the Zacks Consensus Estimate of $2.33. The bottom line decreased 6% year over year. The company has also completed its previously announced acquisition of Atrion Corporation (ATRI) . Quarterly Results of NDSN Nordson's revenues were $661.6 million, up 2% from the year-ago fiscal quarter's number driven by solid momentum in the Industrial Precision Solutions segment. Revenues beat the Za ...

Nordson (NASDAQ:NDSN) just reported results for the third quarter of 2024. Nordson reported earnings per share of $2.41. This was above the analyst estimate for EPS of $2.33. The company reported revenue of $661.60 million. This was 0.82% better than the analyst estimate for revenue of $656.23 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and reven ...